Adaptive Biotechnologies Stock

adaptivebiotech.comHealthcareFounded: 2009Funding to Date: $561.37MM

Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Register for Details

For more details on financing and valuation for Adaptive Biotechnologies, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Adaptive Biotechnologies.

Register Today

Team

Management Team

JULIE RUBINSTEIN
President
SEAN NOLAN
Chief Technical Officer
CHAD ROBINS
Chief Executive Officer, Co-founder
LANCE BALDO
Chief Medical Officer
HARLAN ROBINS, PHD
Chief Scientific Officer, Co-founder
CHAD COHEN
Chief Financial Officer

Board Members

PETER NEUPERT
Operating Partner at Health Evolution Partners
MIKE PELLINI, MD
MICHELLE GRIFFIN
Adaptive Biotechnologies
ANDRIS ZOLTNERS
Self
KEVIN CONROY
DAVID GOEL
Matrix Capital Management
CHAD ROBINS
Adaptive Biotechnologies
ERIC DOBMEIER
Adaptive Biotechnologies
ROBERT HERSHBERG, MD, PhD
Celgene

Other companies like Adaptive Biotechnologies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$885.01MM
Sector